Your AI-Trained Oncology Knowledge Connection!

Halle C. F. Moore, MD

home / authors / halle-c-f-moore-md

Articles

37 Open-Label, Phase 2, Multicenter Study of Lasofoxifene (LAS) Combined With Abemaciclib (Abema) for Treating Pre- and Postmenopausal Women With Locally Advanced or Metastatic ER+/HER2− Breast Cancer and an ESR1 Mutation After Progression on Prior Therapies

David J. Portman;Senthil Damodaran;Paul V. Plourde;Halle C. F. Moore, MD;Ian C. Anderson

April 27th 2023

Meta-Analysis: GnRH Analog Preserves Ovarian Function in Early Breast Cancer

Halle C. F. Moore, MD

December 14th 2017

This video reviews a meta-analysis that looked at five studies testing the use of a gonadotropin-releasing hormone (GnRH) analog to protect ovarian function and preserve fertility in premenopausal women undergoing chemotherapy for early-stage breast cancer.

An Overview of Chemotherapy-Related Cognitive Dysfunction, or ‘Chemobrain’

Halle C. F. Moore, MD

September 15th 2014

This review will focus largely on the effects of systemic cytotoxic treatment on cognitive function, reflecting what has been most extensively studied in the literature.